Health
People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds
Headline as filed by Medical Xpress. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, Medical Xpress, has reported this so far, at 01:00 UTC on 29 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
Medical Xpress
People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds
Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the
Read on Medical Xpress →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.